μ‐Opioid receptors in primary sensory neurons are essential for opioid analgesic effect on acute and inflammatory pain and opioid‐induced hyperalgesia
Key points μ‐Opioid receptors (MORs) are expressed peripherally and centrally, but the loci of MORs responsible for clinically relevant opioid analgesia are uncertain. Crossing Oprm1flox/flox and AdvillinCre/+ mice completely ablates MORs in dorsal root ganglion neurons and reduces the MOR expressio...
Saved in:
| Published in | The Journal of physiology Vol. 597; no. 6; pp. 1661 - 1675 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
Wiley Subscription Services, Inc
01.03.2019
John Wiley and Sons Inc |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Key points
μ‐Opioid receptors (MORs) are expressed peripherally and centrally, but the loci of MORs responsible for clinically relevant opioid analgesia are uncertain.
Crossing Oprm1flox/flox and AdvillinCre/+ mice completely ablates MORs in dorsal root ganglion neurons and reduces the MOR expression level in the spinal cord.
Presynaptic MORs expressed at primary afferent central terminals are essential for synaptic inhibition and potentiation of sensory input by opioids.
MOR ablation in primary sensory neurons diminishes analgesic effects produced by systemic and intrathecal opioid agonists and abolishes chronic opioid treatment‐induced hyperalgesia.
These findings demonstrate a critical role of MORs expressed in primary sensory neurons in opioid analgesia and suggest new strategies to increase the efficacy and reduce adverse effects of opioids.
The pain and analgesic systems are complex, and the actions of systemically administered opioids may be mediated by simultaneous activation of μ‐opioid receptors (MORs, encoded by the Oprm1 gene) at multiple, interacting sites. The loci of MORs and circuits responsible for systemic opioid‐induced analgesia and hyperalgesia remain unclear. Previous studies using mice in which MORs are removed from Nav1.8‐ or TRPV1‐expressing neurons provided only an incomplete and erroneous view about the role of peripheral MORs in opioid actions in vivo. In the present study, we determined the specific role of MORs expressed in primary sensory neurons in the analgesic and hyperalgesic effects produced by systemic opioid administration. We generated Oprm1 conditional knockout (Oprm1‐cKO) mice in which MOR expression is completely deleted from dorsal root ganglion neurons and substantially reduced in the spinal cord, which was confirmed by immunoblotting and immunocytochemical labelling. Both opioid‐induced inhibition and potentiation of primary sensory input were abrogated in Oprm1‐cKO mice. Remarkably, systemically administered morphine potently inhibited acute thermal and mechanical nociception and persistent inflammatory pain in control mice but had little effect in Oprm1‐cKO mice. The analgesic effect of intrathecally administered morphine was also profoundly reduced in Oprm1‐cKO mice. Additionally, chronic morphine treatment‐induced hyperalgesia was absent in Oprm1‐cKO mice. Our findings directly challenge the notion that clinically relevant opioid analgesia is mediated mostly by centrally expressed MORs. MORs in primary sensory neurons, particularly those expressed presynaptically at the first sensory synapse in the spinal cord, are crucial for both opioid analgesia and opioid‐induced hyperalgesia.
Key points
μ‐Opioid receptors (MORs) are expressed peripherally and centrally, but the loci of MORs responsible for clinically relevant opioid analgesia are uncertain.
Crossing Oprm1flox/flox and AdvillinCre/+ mice completely ablates MORs in dorsal root ganglion neurons and reduces the MOR expression level in the spinal cord.
Presynaptic MORs expressed at primary afferent central terminals are essential for synaptic inhibition and potentiation of sensory input by opioids.
MOR ablation in primary sensory neurons diminishes analgesic effects produced by systemic and intrathecal opioid agonists and abolishes chronic opioid treatment‐induced hyperalgesia.
These findings demonstrate a critical role of MORs expressed in primary sensory neurons in opioid analgesia and suggest new strategies to increase the efficacy and reduce adverse effects of opioids. |
|---|---|
| AbstractList | μ-Opioid receptors (MORs) are expressed peripherally and centrally, but the loci of MORs responsible for clinically relevant opioid analgesia are uncertain. Crossing Oprm1
and Advillin
mice completely ablates MORs in dorsal root ganglion neurons and reduces the MOR expression level in the spinal cord. Presynaptic MORs expressed at primary afferent central terminals are essential for synaptic inhibition and potentiation of sensory input by opioids. MOR ablation in primary sensory neurons diminishes analgesic effects produced by systemic and intrathecal opioid agonists and abolishes chronic opioid treatment-induced hyperalgesia. These findings demonstrate a critical role of MORs expressed in primary sensory neurons in opioid analgesia and suggest new strategies to increase the efficacy and reduce adverse effects of opioids.
The pain and analgesic systems are complex, and the actions of systemically administered opioids may be mediated by simultaneous activation of μ-opioid receptors (MORs, encoded by the Oprm1 gene) at multiple, interacting sites. The loci of MORs and circuits responsible for systemic opioid-induced analgesia and hyperalgesia remain unclear. Previous studies using mice in which MORs are removed from Nav1.8- or TRPV1-expressing neurons provided only an incomplete and erroneous view about the role of peripheral MORs in opioid actions in vivo. In the present study, we determined the specific role of MORs expressed in primary sensory neurons in the analgesic and hyperalgesic effects produced by systemic opioid administration. We generated Oprm1 conditional knockout (Oprm1-cKO) mice in which MOR expression is completely deleted from dorsal root ganglion neurons and substantially reduced in the spinal cord, which was confirmed by immunoblotting and immunocytochemical labelling. Both opioid-induced inhibition and potentiation of primary sensory input were abrogated in Oprm1-cKO mice. Remarkably, systemically administered morphine potently inhibited acute thermal and mechanical nociception and persistent inflammatory pain in control mice but had little effect in Oprm1-cKO mice. The analgesic effect of intrathecally administered morphine was also profoundly reduced in Oprm1-cKO mice. Additionally, chronic morphine treatment-induced hyperalgesia was absent in Oprm1-cKO mice. Our findings directly challenge the notion that clinically relevant opioid analgesia is mediated mostly by centrally expressed MORs. MORs in primary sensory neurons, particularly those expressed presynaptically at the first sensory synapse in the spinal cord, are crucial for both opioid analgesia and opioid-induced hyperalgesia. μ-Opioid receptors (MORs) are expressed peripherally and centrally, but the loci of MORs responsible for clinically relevant opioid analgesia are uncertain. Crossing Oprm1flox/flox and AdvillinCre/+ mice completely ablates MORs in dorsal root ganglion neurons and reduces the MOR expression level in the spinal cord. Presynaptic MORs expressed at primary afferent central terminals are essential for synaptic inhibition and potentiation of sensory input by opioids. MOR ablation in primary sensory neurons diminishes analgesic effects produced by systemic and intrathecal opioid agonists and abolishes chronic opioid treatment-induced hyperalgesia. These findings demonstrate a critical role of MORs expressed in primary sensory neurons in opioid analgesia and suggest new strategies to increase the efficacy and reduce adverse effects of opioids.KEY POINTSμ-Opioid receptors (MORs) are expressed peripherally and centrally, but the loci of MORs responsible for clinically relevant opioid analgesia are uncertain. Crossing Oprm1flox/flox and AdvillinCre/+ mice completely ablates MORs in dorsal root ganglion neurons and reduces the MOR expression level in the spinal cord. Presynaptic MORs expressed at primary afferent central terminals are essential for synaptic inhibition and potentiation of sensory input by opioids. MOR ablation in primary sensory neurons diminishes analgesic effects produced by systemic and intrathecal opioid agonists and abolishes chronic opioid treatment-induced hyperalgesia. These findings demonstrate a critical role of MORs expressed in primary sensory neurons in opioid analgesia and suggest new strategies to increase the efficacy and reduce adverse effects of opioids.The pain and analgesic systems are complex, and the actions of systemically administered opioids may be mediated by simultaneous activation of μ-opioid receptors (MORs, encoded by the Oprm1 gene) at multiple, interacting sites. The loci of MORs and circuits responsible for systemic opioid-induced analgesia and hyperalgesia remain unclear. Previous studies using mice in which MORs are removed from Nav1.8- or TRPV1-expressing neurons provided only an incomplete and erroneous view about the role of peripheral MORs in opioid actions in vivo. In the present study, we determined the specific role of MORs expressed in primary sensory neurons in the analgesic and hyperalgesic effects produced by systemic opioid administration. We generated Oprm1 conditional knockout (Oprm1-cKO) mice in which MOR expression is completely deleted from dorsal root ganglion neurons and substantially reduced in the spinal cord, which was confirmed by immunoblotting and immunocytochemical labelling. Both opioid-induced inhibition and potentiation of primary sensory input were abrogated in Oprm1-cKO mice. Remarkably, systemically administered morphine potently inhibited acute thermal and mechanical nociception and persistent inflammatory pain in control mice but had little effect in Oprm1-cKO mice. The analgesic effect of intrathecally administered morphine was also profoundly reduced in Oprm1-cKO mice. Additionally, chronic morphine treatment-induced hyperalgesia was absent in Oprm1-cKO mice. Our findings directly challenge the notion that clinically relevant opioid analgesia is mediated mostly by centrally expressed MORs. MORs in primary sensory neurons, particularly those expressed presynaptically at the first sensory synapse in the spinal cord, are crucial for both opioid analgesia and opioid-induced hyperalgesia.ABSTRACTThe pain and analgesic systems are complex, and the actions of systemically administered opioids may be mediated by simultaneous activation of μ-opioid receptors (MORs, encoded by the Oprm1 gene) at multiple, interacting sites. The loci of MORs and circuits responsible for systemic opioid-induced analgesia and hyperalgesia remain unclear. Previous studies using mice in which MORs are removed from Nav1.8- or TRPV1-expressing neurons provided only an incomplete and erroneous view about the role of peripheral MORs in opioid actions in vivo. In the present study, we determined the specific role of MORs expressed in primary sensory neurons in the analgesic and hyperalgesic effects produced by systemic opioid administration. We generated Oprm1 conditional knockout (Oprm1-cKO) mice in which MOR expression is completely deleted from dorsal root ganglion neurons and substantially reduced in the spinal cord, which was confirmed by immunoblotting and immunocytochemical labelling. Both opioid-induced inhibition and potentiation of primary sensory input were abrogated in Oprm1-cKO mice. Remarkably, systemically administered morphine potently inhibited acute thermal and mechanical nociception and persistent inflammatory pain in control mice but had little effect in Oprm1-cKO mice. The analgesic effect of intrathecally administered morphine was also profoundly reduced in Oprm1-cKO mice. Additionally, chronic morphine treatment-induced hyperalgesia was absent in Oprm1-cKO mice. Our findings directly challenge the notion that clinically relevant opioid analgesia is mediated mostly by centrally expressed MORs. MORs in primary sensory neurons, particularly those expressed presynaptically at the first sensory synapse in the spinal cord, are crucial for both opioid analgesia and opioid-induced hyperalgesia. The pain and analgesic systems are complex, and the actions of systemically administered opioids may be mediated by simultaneous activation of μ‐opioid receptors (MORs, encoded by the Oprm1 gene) at multiple, interacting sites. The loci of MORs and circuits responsible for systemic opioid‐induced analgesia and hyperalgesia remain unclear. Previous studies using mice in which MORs are removed from Nav1.8‐ or TRPV1‐expressing neurons provided only an incomplete and erroneous view about the role of peripheral MORs in opioid actions in vivo. In the present study, we determined the specific role of MORs expressed in primary sensory neurons in the analgesic and hyperalgesic effects produced by systemic opioid administration. We generated Oprm1 conditional knockout (Oprm1‐cKO) mice in which MOR expression is completely deleted from dorsal root ganglion neurons and substantially reduced in the spinal cord, which was confirmed by immunoblotting and immunocytochemical labelling. Both opioid‐induced inhibition and potentiation of primary sensory input were abrogated in Oprm1‐cKO mice. Remarkably, systemically administered morphine potently inhibited acute thermal and mechanical nociception and persistent inflammatory pain in control mice but had little effect in Oprm1‐cKO mice. The analgesic effect of intrathecally administered morphine was also profoundly reduced in Oprm1‐cKO mice. Additionally, chronic morphine treatment‐induced hyperalgesia was absent in Oprm1‐cKO mice. Our findings directly challenge the notion that clinically relevant opioid analgesia is mediated mostly by centrally expressed MORs. MORs in primary sensory neurons, particularly those expressed presynaptically at the first sensory synapse in the spinal cord, are crucial for both opioid analgesia and opioid‐induced hyperalgesia. μ‐Opioid receptors (MORs) are expressed peripherally and centrally, but the loci of MORs responsible for clinically relevant opioid analgesia are uncertain. Crossing Oprm1 flox/flox and Advillin Cre/+ mice completely ablates MORs in dorsal root ganglion neurons and reduces the MOR expression level in the spinal cord. Presynaptic MORs expressed at primary afferent central terminals are essential for synaptic inhibition and potentiation of sensory input by opioids. MOR ablation in primary sensory neurons diminishes analgesic effects produced by systemic and intrathecal opioid agonists and abolishes chronic opioid treatment‐induced hyperalgesia. These findings demonstrate a critical role of MORs expressed in primary sensory neurons in opioid analgesia and suggest new strategies to increase the efficacy and reduce adverse effects of opioids. Key points μ‐Opioid receptors (MORs) are expressed peripherally and centrally, but the loci of MORs responsible for clinically relevant opioid analgesia are uncertain. Crossing Oprm1flox/flox and AdvillinCre/+ mice completely ablates MORs in dorsal root ganglion neurons and reduces the MOR expression level in the spinal cord. Presynaptic MORs expressed at primary afferent central terminals are essential for synaptic inhibition and potentiation of sensory input by opioids. MOR ablation in primary sensory neurons diminishes analgesic effects produced by systemic and intrathecal opioid agonists and abolishes chronic opioid treatment‐induced hyperalgesia. These findings demonstrate a critical role of MORs expressed in primary sensory neurons in opioid analgesia and suggest new strategies to increase the efficacy and reduce adverse effects of opioids. The pain and analgesic systems are complex, and the actions of systemically administered opioids may be mediated by simultaneous activation of μ‐opioid receptors (MORs, encoded by the Oprm1 gene) at multiple, interacting sites. The loci of MORs and circuits responsible for systemic opioid‐induced analgesia and hyperalgesia remain unclear. Previous studies using mice in which MORs are removed from Nav1.8‐ or TRPV1‐expressing neurons provided only an incomplete and erroneous view about the role of peripheral MORs in opioid actions in vivo. In the present study, we determined the specific role of MORs expressed in primary sensory neurons in the analgesic and hyperalgesic effects produced by systemic opioid administration. We generated Oprm1 conditional knockout (Oprm1‐cKO) mice in which MOR expression is completely deleted from dorsal root ganglion neurons and substantially reduced in the spinal cord, which was confirmed by immunoblotting and immunocytochemical labelling. Both opioid‐induced inhibition and potentiation of primary sensory input were abrogated in Oprm1‐cKO mice. Remarkably, systemically administered morphine potently inhibited acute thermal and mechanical nociception and persistent inflammatory pain in control mice but had little effect in Oprm1‐cKO mice. The analgesic effect of intrathecally administered morphine was also profoundly reduced in Oprm1‐cKO mice. Additionally, chronic morphine treatment‐induced hyperalgesia was absent in Oprm1‐cKO mice. Our findings directly challenge the notion that clinically relevant opioid analgesia is mediated mostly by centrally expressed MORs. MORs in primary sensory neurons, particularly those expressed presynaptically at the first sensory synapse in the spinal cord, are crucial for both opioid analgesia and opioid‐induced hyperalgesia. Key points μ‐Opioid receptors (MORs) are expressed peripherally and centrally, but the loci of MORs responsible for clinically relevant opioid analgesia are uncertain. Crossing Oprm1flox/flox and AdvillinCre/+ mice completely ablates MORs in dorsal root ganglion neurons and reduces the MOR expression level in the spinal cord. Presynaptic MORs expressed at primary afferent central terminals are essential for synaptic inhibition and potentiation of sensory input by opioids. MOR ablation in primary sensory neurons diminishes analgesic effects produced by systemic and intrathecal opioid agonists and abolishes chronic opioid treatment‐induced hyperalgesia. These findings demonstrate a critical role of MORs expressed in primary sensory neurons in opioid analgesia and suggest new strategies to increase the efficacy and reduce adverse effects of opioids. |
| Author | Pan, Hui‐Lin Chen, Shao‐Rui Sun, Jie Chen, Hong |
| AuthorAffiliation | 2 Department of Anesthesiology The First Affiliated Hospital/Jiangsu Province Hospital Nanjing Medical University Nanjing Jiangsu 210029 China 1 Center for Neuroscience and Pain Research Department of Anesthesiology and Perioperative Medicine The University of Texas MD Anderson Cancer Center Houston TX 77030 USA |
| AuthorAffiliation_xml | – name: 1 Center for Neuroscience and Pain Research Department of Anesthesiology and Perioperative Medicine The University of Texas MD Anderson Cancer Center Houston TX 77030 USA – name: 2 Department of Anesthesiology The First Affiliated Hospital/Jiangsu Province Hospital Nanjing Medical University Nanjing Jiangsu 210029 China |
| Author_xml | – sequence: 1 givenname: Jie surname: Sun fullname: Sun, Jie organization: Nanjing Medical University – sequence: 2 givenname: Shao‐Rui surname: Chen fullname: Chen, Shao‐Rui organization: The University of Texas MD Anderson Cancer Center – sequence: 3 givenname: Hong surname: Chen fullname: Chen, Hong organization: The University of Texas MD Anderson Cancer Center – sequence: 4 givenname: Hui‐Lin orcidid: 0000-0001-8444-3770 surname: Pan fullname: Pan, Hui‐Lin email: huilinpan@mdanderson.org organization: The University of Texas MD Anderson Cancer Center |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30578671$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kktu1TAUhi1URG8LEitAlpgwSfEr1_YECVW8qkrtoIwtxzlpXeXawU5Ad8YSmLMV1sAiWAmOcm95CEaWfL7z-bd9jtBBiAEQekzJCaWUPz-7ZFIKpu6hFRVrXUmp-QFaEcJYxWVND9FRzreEUE60foAOOamlWku6Ql-_f_vx-cvF4KNvcQIHwxhTxj7gIfmNTVucIeRY1gBTiiFjmwBDLrujtz3uYsJx6bbB9teQvcPQdeBGHAO2bhqhVNpi7Hq72dhxdg22HDDvLq0lgQ_t5KDFN9sB0uKxD9H9zvYZHu3WY_T-9aur07fV-cWbd6cvzysnuGZVo7hdW9FQJZhgUjUCiLOUaEto21DesLqT2hHa6U4y2yrZCFGARgLXtCb8GL1YvMPUbKB15Wolgtk9gInWmz8rwd-Y6_jRrAVVspZF8GwnSPHDBHk0G58d9L0NEKdsGK21VqRmdUGf_oXeximVl5spTZmSgszCJ78nuouy_7cCnCyASzHnBJ1xfrSjj3NA3xtKzDwYZj8YvyLeNeyd_0B37k--h-1_OXN1dkk5V4z_BIZay0k |
| CitedBy_id | crossref_primary_10_1021_acschemneuro_2c00780 crossref_primary_10_3389_fnmol_2023_1171855 crossref_primary_10_1016_j_peptides_2021_170547 crossref_primary_10_1523_JNEUROSCI_0601_23_2023 crossref_primary_10_2139_ssrn_3984031 crossref_primary_10_1016_j_ejphar_2024_176457 crossref_primary_10_1111_bph_15471 crossref_primary_10_1016_j_brainres_2019_146623 crossref_primary_10_1016_j_neuropharm_2023_109597 crossref_primary_10_1111_ejn_16617 crossref_primary_10_1007_s00213_024_06719_1 crossref_primary_10_1074_jbc_RA119_011053 crossref_primary_10_1136_rapm_2020_101779 crossref_primary_10_1523_JNEUROSCI_1943_23_2023 crossref_primary_10_1097_SPC_0000000000000495 crossref_primary_10_1523_JNEUROSCI_0392_24_2024 crossref_primary_10_1523_JNEUROSCI_1704_22_2022 crossref_primary_10_3389_fphar_2022_862539 crossref_primary_10_1111_jnc_15706 crossref_primary_10_1186_s13041_020_00599_0 crossref_primary_10_1016_j_biopha_2025_117847 crossref_primary_10_1021_acschemneuro_1c00841 crossref_primary_10_1016_j_neuropharm_2022_109202 crossref_primary_10_3389_fphar_2024_1344123 crossref_primary_10_3390_molecules25112473 crossref_primary_10_1016_j_jbc_2022_101999 crossref_primary_10_1038_s41467_024_54054_y crossref_primary_10_1021_acschemneuro_4c00732 crossref_primary_10_1177_17448069231181973 crossref_primary_10_1177_0269881120985183 crossref_primary_10_1016_j_bioactmat_2022_10_007 crossref_primary_10_2174_1875692117666191211154755 crossref_primary_10_1016_j_neuroscience_2019_06_007 crossref_primary_10_1016_j_ejphar_2021_174007 crossref_primary_10_1590__1678_9199_jvatitd_2019_0043 crossref_primary_10_3389_fpsyg_2024_1361857 crossref_primary_10_1002_jnr_24626 crossref_primary_10_3390_ijms26052356 crossref_primary_10_1038_s41598_020_61224_7 crossref_primary_10_1523_JNEUROSCI_1368_23_2023 crossref_primary_10_1038_s41598_019_55886_1 crossref_primary_10_1523_JNEUROSCI_1790_24_2024 crossref_primary_10_2147_JPR_S333297 crossref_primary_10_7554_eLife_55289 crossref_primary_10_1523_JNEUROSCI_0183_23_2023 crossref_primary_10_1590_1678_9199_jvatitd_2019_0043 crossref_primary_10_1097_j_pain_0000000000001602 crossref_primary_10_1016_j_jrras_2023_100682 crossref_primary_10_1038_s41598_024_74487_1 crossref_primary_10_1016_j_ynpai_2023_100146 crossref_primary_10_1152_physiol_00014_2021 crossref_primary_10_3389_fphys_2023_1043581 crossref_primary_10_1126_scitranslmed_abj9837 crossref_primary_10_1111_jnc_15127 |
| Cites_doi | 10.1523/JNEUROSCI.4908-07.2007 10.1016/0006-8993(95)00446-W 10.1523/JNEUROSCI.2530-06.2006 10.1111/j.1469-7793.1999.0803p.x 10.1186/1744-8069-4-10 10.1097/ALN.0b013e3182887526 10.1038/35047086 10.1074/jbc.M112.378737 10.1073/pnas.0607394104 10.1097/00000542-200002000-00029 10.1111/bph.14148 10.1073/pnas.1014411108 10.1038/nrn3210 10.1371/journal.pone.0074706 10.1073/pnas.0914725107 10.1523/JNEUROSCI.14-06-03842.1994 10.1074/jbc.M115.711812 10.1016/0006-8993(86)90601-3 10.1523/JNEUROSCI.3693-06.2006 10.1016/j.neuroscience.2006.12.016 10.1523/JNEUROSCI.14-04-02301.1994 10.1016/S0006-8993(02)02242-4 10.1007/978-1-4939-1708-2_11 10.1016/j.cell.2011.08.043 10.1073/pnas.94.4.1544 10.1016/0165-0270(94)90144-9 10.1093/bja/81.2.208 10.1124/jpet.108.141226 10.1016/j.neuroimage.2016.07.030 10.1016/j.neuroscience.2005.06.003 10.1016/j.brainres.2006.01.053 10.1016/0014-2999(80)90515-4 10.2174/157015911795016921 10.1523/JNEUROSCI.4899-04.2005 10.1523/JNEUROSCI.5541-09.2010 10.1523/JNEUROSCI.5857-09.2010 10.1016/j.pain.2014.07.011 10.1038/383819a0 10.1038/s41598-017-11120-4 10.1152/jn.01343.2005 10.1124/jpet.300.2.588 10.1152/jn.00575.2001 10.1038/nm.4262 10.1124/jpet.104.073429 |
| ContentType | Journal Article |
| Copyright | 2018 The Authors. The Journal of Physiology © 2018 The Physiological Society 2018 The Authors. The Journal of Physiology © 2018 The Physiological Society. Journal compilation © 2019 The Physiological Society |
| Copyright_xml | – notice: 2018 The Authors. The Journal of Physiology © 2018 The Physiological Society – notice: 2018 The Authors. The Journal of Physiology © 2018 The Physiological Society. – notice: Journal compilation © 2019 The Physiological Society |
| DBID | AAYXX CITATION NPM 7QP 7QR 7TK 7TS 8FD FR3 P64 7X8 5PM |
| DOI | 10.1113/JP277428 |
| DatabaseName | CrossRef PubMed Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Neurosciences Abstracts Physical Education Index Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef PubMed Technology Research Database Chemoreception Abstracts Engineering Research Database Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Physical Education Index Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic Technology Research Database CrossRef |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Anatomy & Physiology |
| DocumentTitleAlternate | J. Sun and others |
| EISSN | 1469-7793 |
| EndPage | 1675 |
| ExternalDocumentID | PMC6418757 30578671 10_1113_JP277428 TJP13382 |
| Genre | article Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: National Institutes of Health funderid: No. R01 DA041711 – fundername: National Institute on Drug Abuse funderid: DA041711 – fundername: N.G. and Helen T. Hawkins Endowment – fundername: NIDA NIH HHS grantid: R01 DA041711 – fundername: National Institutes of Health grantid: No. R01 DA041711 – fundername: National Institute on Drug Abuse grantid: DA041711 |
| GroupedDBID | --- -DZ -~X .3N .GA 05W 0R~ 10A 123 18M 1OC 24P 29L 2WC 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAFWJ AAHHS AAHQN AAIPD AAMNL AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABITZ ABIVO ABJNI ABOCM ABPPZ ABPVW ABQWH ABXGK ACAHQ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOF ACIWK ACMXC ACNCT ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AI. AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB AOIJS ATUGU AZBYB AZVAB BAFTC BAWUL BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM E3Z EBS EJD EMOBN EX3 F00 F01 F04 F5P FIJ FUBAC G-S G.N GODZA GX1 H.X HGLYW HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D Q.N Q11 QB0 R.K ROL RPM RX1 SUPJJ TEORI TLM TN5 TR2 UB1 UPT V8K VH1 W8F W8V W99 WBKPD WH7 WIH WIJ WIK WIN WNSPC WOHZO WOQ WOW WQJ WRC WXI WXSBR WYISQ XG1 YBU YHG YKV YQT YSK YZZ ZZTAW ~IA ~WT .55 .GJ .Y3 0YM 31~ 3EH 3O- AAYJJ AAYXX ADXHL AEYWJ AFFNX AGHNM AGYGG C1A CAG CHEAL CITATION COF FA8 H13 HF~ H~9 LW6 MVM NEJ OHT RIG UKR WHG X7M XOL YXB YYP ZGI ZXP NPM 7QP 7QR 7TK 7TS 8FD FR3 P64 7X8 5PM |
| ID | FETCH-LOGICAL-c4392-b83a6a4b18424278b4e0ca109a01db13b25f79c01f9f72ad87b44ca1b7e391503 |
| IEDL.DBID | DR2 |
| ISSN | 0022-3751 1469-7793 |
| IngestDate | Thu Aug 21 14:40:03 EDT 2025 Fri Jul 11 04:45:35 EDT 2025 Fri Jul 25 12:04:52 EDT 2025 Thu Apr 03 07:07:08 EDT 2025 Thu Apr 24 22:59:43 EDT 2025 Tue Jul 01 04:29:25 EDT 2025 Wed Jan 22 16:48:30 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | opioid analgesic tolerance presynaptic inhibition synaptic transmission TRPV1 fentanyl opiate |
| Language | English |
| License | 2018 The Authors. The Journal of Physiology © 2018 The Physiological Society. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4392-b83a6a4b18424278b4e0ca109a01db13b25f79c01f9f72ad87b44ca1b7e391503 |
| Notes | Edited by: Ian Forsythe & David Grundy ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0001-8444-3770 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/6418757 |
| PMID | 30578671 |
| PQID | 2191287407 |
| PQPubID | 1086388 |
| PageCount | 15 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6418757 proquest_miscellaneous_2159980525 proquest_journals_2191287407 pubmed_primary_30578671 crossref_citationtrail_10_1113_JP277428 crossref_primary_10_1113_JP277428 wiley_primary_10_1113_JP277428_TJP13382 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2019-03-00 |
| PublicationDateYYYYMMDD | 2019-03-01 |
| PublicationDate_xml | – month: 03 year: 2019 text: 2019-03-00 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London – name: Hoboken |
| PublicationTitle | The Journal of physiology |
| PublicationTitleAlternate | J Physiol |
| PublicationYear | 2019 |
| Publisher | Wiley Subscription Services, Inc John Wiley and Sons Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc – name: John Wiley and Sons Inc |
| References | 2007; 145 2017; 7 2010a; 30 1986; 399 2012; 287 2005; 135 1980; 67 2017; 23 2000; 92 2008; 327 2002; 930 1998; 81 2008; 4 1996; 383 2006b; 95 2014; 155 2012; 13 2013; 8 2016; 141 2015; 1230 2011; 9 2005; 25 2018; 175 2000; 408 2011; 147 2011; 108 1997; 94 2004; 311 2002; 300 2013; 118 2002; 87 2006; 26 2006a; 1081 1994; 14 1995; 687 2010b; 107 2016; 291 2010; 30 1999; 518 2006; 103 1994; 53 2007; 27 e_1_2_5_27_1 e_1_2_5_28_1 e_1_2_5_25_1 e_1_2_5_26_1 e_1_2_5_23_1 e_1_2_5_24_1 e_1_2_5_45_1 e_1_2_5_21_1 e_1_2_5_44_1 e_1_2_5_22_1 e_1_2_5_43_1 e_1_2_5_29_1 e_1_2_5_42_1 e_1_2_5_20_1 e_1_2_5_41_1 e_1_2_5_40_1 e_1_2_5_15_1 e_1_2_5_38_1 e_1_2_5_14_1 e_1_2_5_39_1 e_1_2_5_17_1 e_1_2_5_36_1 e_1_2_5_9_1 e_1_2_5_16_1 e_1_2_5_37_1 e_1_2_5_8_1 e_1_2_5_11_1 e_1_2_5_34_1 e_1_2_5_7_1 e_1_2_5_10_1 e_1_2_5_35_1 e_1_2_5_6_1 e_1_2_5_13_1 e_1_2_5_32_1 e_1_2_5_5_1 e_1_2_5_12_1 e_1_2_5_33_1 e_1_2_5_4_1 e_1_2_5_3_1 e_1_2_5_2_1 e_1_2_5_19_1 e_1_2_5_18_1 e_1_2_5_30_1 e_1_2_5_31_1 |
| References_xml | – volume: 1081 start-page: 119 year: 2006a end-page: 125 article-title: Blocking mu opioid receptors in the spinal cord prevents the analgesic action by subsequent systemic opioids publication-title: Brain Res – volume: 311 start-page: 939 year: 2004 end-page: 947 article-title: Differential sensitivity of N‐ and P/Q‐type Ca channel currents to a mu opioid in isolectin B4‐positive and ‐negative dorsal root ganglion neurons publication-title: J Pharmacol Exp Ther – volume: 287 start-page: 25073 year: 2012 end-page: 25085 article-title: Chronic opioid potentiates presynaptic but impairs postsynaptic N‐methyl‐D‐aspartic acid receptor activity in spinal cords: implications for opioid hyperalgesia and tolerance publication-title: J Biol Chem – volume: 9 start-page: 219 year: 2011 end-page: 222 article-title: Quantitative detection of μ opioid receptor: Western Blot analyses using μ opioid receptor knockout mice publication-title: Curr Neuropharmacol – volume: 135 start-page: 247 year: 2005 end-page: 261 article-title: Ultra‐low‐dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor‐G protein coupling and Gβγ signaling publication-title: Neuroscience – volume: 930 start-page: 150 year: 2002 end-page: 162 article-title: Mu and delta opioid receptor‐like immunoreactivity in the cervical spinal cord of the rat after dorsal rhizotomy or neonatal capsaicin: an analysis of pre‐ and postsynaptic receptor distributions publication-title: Brain Res – volume: 30 start-page: 4460 year: 2010a end-page: 4466 article-title: Opioid‐induced long‐term potentiation in the spinal cord is a presynaptic event publication-title: J Neurosci – volume: 141 start-page: 81 year: 2016 end-page: 87 article-title: Human dorsal‐root‐ganglion perfusion measured in‐vivo by MRI publication-title: Neuroimage – volume: 300 start-page: 588 year: 2002 end-page: 596 article-title: Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats publication-title: J Pharmacol Exp Ther – volume: 53 start-page: 55 year: 1994 end-page: 63 article-title: Quantitative assessment of tactile allodynia in the rat paw publication-title: J Neurosci Methods – volume: 26 start-page: 12251 year: 2006 end-page: 12259 article-title: Distinct populations of spinal cord lamina II interneurons expressing G‐protein‐gated potassium channels publication-title: J Neurosci – volume: 14 start-page: 3842 year: 1994 end-page: 3851 article-title: mu‐Opioid receptor‐mediated reduction of neuronal calcium current occurs via a G ‐type GTP‐binding protein publication-title: J Neurosci – volume: 94 start-page: 1544 year: 1997 end-page: 1549 article-title: Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine‐induced analgesia publication-title: Proc Natl Acad Sci U S A – volume: 103 start-page: 19919 year: 2006 end-page: 19924 article-title: Axonal mRNA transport and localized translational regulation of kappa‐opioid receptor in primary neurons of dorsal root ganglia publication-title: Proc Natl Acad Sci U S A – volume: 30 start-page: 4806 year: 2010 end-page: 4814 article-title: Epigenetic gene silencing underlies C‐fiber dysfunctions in neuropathic pain publication-title: J Neurosci – volume: 518 start-page: 803 year: 1999 end-page: 813 article-title: Actions of opioids on excitatory and inhibitory transmission in substantia gelatinosa of adult rat spinal cord publication-title: J Physiol – volume: 14 start-page: 2301 year: 1994 end-page: 2312 article-title: Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C publication-title: J Neurosci – volume: 67 start-page: 313 year: 1980 end-page: 316 article-title: Intrathecal morphine in mice: a new technique publication-title: Eur J Pharmacol – volume: 81 start-page: 208 year: 1998 end-page: 215 article-title: Pharmacological evidence for different alpha 2‐adrenergic receptor sites mediating analgesia and sedation in the rat publication-title: Br J Anaesth – volume: 26 start-page: 12033 year: 2006 end-page: 12042 article-title: Primary afferent NMDA receptors increase dorsal horn excitation and mediate opiate tolerance in neonatal rats publication-title: J Neurosci – volume: 327 start-page: 375 year: 2008 end-page: 382 article-title: Sustained inhibition of neurotransmitter release from nontransient receptor potential vanilloid type 1‐expressing primary afferents by mu‐opioid receptor activation‐enkephalin in the spinal cord publication-title: J Pharmacol Exp Ther – volume: 408 start-page: 720 year: 2000 end-page: 723 article-title: Mu‐opioid receptor desensitization by beta‐arrestin‐2 determines morphine tolerance but not dependence publication-title: Nature – volume: 145 start-page: 676 year: 2007 end-page: 685 article-title: Resistance to morphine analgesic tolerance in rats with deleted transient receptor potential vanilloid type 1‐expressing sensory neurons publication-title: Neuroscience – volume: 175 start-page: 2013 year: 2018 end-page: 2027 article-title: In vivo effects of mu‐opioid receptor agonist/delta‐opioid receptor antagonist peptidomimetics following acute and repeated administration publication-title: Br J Pharmacol – volume: 13 start-page: 308 year: 2012 end-page: 324 article-title: Axonal mRNA localization and local protein synthesis in nervous system assembly, maintenance and repair publication-title: Nat Rev Neurosci – volume: 7 start-page: 10406 year: 2017 article-title: Morphine‐induced hyperalgesia involves mu opioid receptors and the metabolite morphine‐3‐glucuronide publication-title: Sci Rep – volume: 27 start-page: 14404 year: 2007 end-page: 14414 article-title: Analyzing somatosensory axon projections with the sensory neuron‐specific gene publication-title: J Neurosci – volume: 118 start-page: 1160 year: 2013 end-page: 1169 article-title: Effects of naloxone on opioid‐induced hyperalgesia and tolerance to remifentanil under sevoflurane anesthesia in rats publication-title: Anesthesiology – volume: 108 start-page: 3395 year: 2011 end-page: 3400 article-title: Proper formation of whisker barrelettes requires periphery‐derived Smad4‐dependent TGF‐beta signaling publication-title: Proc Natl Acad Sci U S A – volume: 687 start-page: 53 year: 1995 end-page: 62 article-title: Changes of opioid binding density in the rat spinal cord following unilateral dorsal rhizotomy publication-title: Brain Res – volume: 23 start-page: 164 year: 2017 end-page: 173 article-title: Loss of mu opioid receptor signaling in nociceptors, but not microglia, abrogates morphine tolerance without disrupting analgesia publication-title: Nat Med – volume: 4 start-page: 10 year: 2008 article-title: Vascularization of the dorsal root ganglia and peripheral nerve of the mouse: implications for chemical‐induced peripheral sensory neuropathies publication-title: Mol Pain – volume: 92 start-page: 465 year: 2000 end-page: 472 article-title: Long‐lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine publication-title: Anesthesiology – volume: 399 start-page: 69 year: 1986 end-page: 79 article-title: Pharmacological and anatomical evidence of selective mu, delta, and kappa opioid receptor binding in rat brain publication-title: Brain Res – volume: 25 start-page: 3551 year: 2005 end-page: 3559 article-title: Spinal G‐protein‐gated potassium channels contribute in a dose‐dependent manner to the analgesic effect of mu‐ and delta‐ but not kappa‐opioids publication-title: J Neurosci – volume: 8 start-page: e74706 year: 2013 article-title: Mu opioid receptors on primary afferent nav1.8 neurons contribute to opiate‐induced analgesia: insight from conditional knockout mice publication-title: PLoS One – volume: 383 start-page: 819 year: 1996 end-page: 823 article-title: Loss of morphine‐induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu‐opioid‐receptor gene publication-title: Nature – volume: 107 start-page: 9424 year: 2010b end-page: 9429 article-title: Deletion of PIK3C3/Vps34 in sensory neurons causes rapid neurodegeneration by disrupting the endosomal but not the autophagic pathway publication-title: Proc Natl Acad Sci U S A – volume: 95 start-page: 3086 year: 2006b end-page: 3096 article-title: Loss of TRPV1‐expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia publication-title: J Neurophysiol – volume: 87 start-page: 1938 year: 2002 end-page: 1947 article-title: Inhibition of glutamatergic synaptic input to spinal lamina II neurons by presynaptic α ‐adrenergic receptors publication-title: J Neurophysiol – volume: 291 start-page: 8475 year: 2016 end-page: 8485 article-title: Nerve injury diminishes opioid analgesia through lysine methyltransferase‐mediated transcriptional repression of mu‐opioid receptors in primary sensory neurons publication-title: J Biol Chem – volume: 1230 start-page: 141 year: 2015 end-page: 154 article-title: Detection of mu opioid receptor (MOPR) and its glycosylation in rat and mouse brains by western blot with anti‐μC, an affinity‐purified polyclonal anti‐MOPR antibody publication-title: Methods Mol Biol – volume: 155 start-page: 2056 year: 2014 end-page: 2062 article-title: Peripheral opioid receptor blockade increases postoperative morphine demands–a randomized, double‐blind, placebo‐controlled trial publication-title: Pain – volume: 147 start-page: 447 year: 2011 end-page: 458 article-title: Unidirectional cross‐activation of GRPR by MOR1D uncouples itch and analgesia induced by opioids publication-title: Cell – ident: e_1_2_5_16_1 doi: 10.1523/JNEUROSCI.4908-07.2007 – ident: e_1_2_5_35_1 doi: 10.1016/0006-8993(95)00446-W – ident: e_1_2_5_40_1 doi: 10.1523/JNEUROSCI.2530-06.2006 – ident: e_1_2_5_23_1 doi: 10.1111/j.1469-7793.1999.0803p.x – ident: e_1_2_5_20_1 doi: 10.1186/1744-8069-4-10 – ident: e_1_2_5_3_1 doi: 10.1097/ALN.0b013e3182887526 – ident: e_1_2_5_6_1 doi: 10.1038/35047086 – ident: e_1_2_5_42_1 doi: 10.1074/jbc.M112.378737 – ident: e_1_2_5_5_1 doi: 10.1073/pnas.0607394104 – ident: e_1_2_5_8_1 doi: 10.1097/00000542-200002000-00029 – ident: e_1_2_5_4_1 doi: 10.1111/bph.14148 – ident: e_1_2_5_14_1 doi: 10.1073/pnas.1014411108 – ident: e_1_2_5_21_1 doi: 10.1038/nrn3210 – ident: e_1_2_5_38_1 doi: 10.1371/journal.pone.0074706 – ident: e_1_2_5_45_1 doi: 10.1073/pnas.0914725107 – ident: e_1_2_5_30_1 doi: 10.1523/JNEUROSCI.14-06-03842.1994 – ident: e_1_2_5_41_1 doi: 10.1074/jbc.M115.711812 – ident: e_1_2_5_25_1 doi: 10.1016/0006-8993(86)90601-3 – ident: e_1_2_5_27_1 doi: 10.1523/JNEUROSCI.3693-06.2006 – ident: e_1_2_5_12_1 doi: 10.1016/j.neuroscience.2006.12.016 – ident: e_1_2_5_26_1 doi: 10.1523/JNEUROSCI.14-04-02301.1994 – ident: e_1_2_5_2_1 doi: 10.1016/S0006-8993(02)02242-4 – ident: e_1_2_5_17_1 doi: 10.1007/978-1-4939-1708-2_11 – ident: e_1_2_5_24_1 doi: 10.1016/j.cell.2011.08.043 – ident: e_1_2_5_34_1 doi: 10.1073/pnas.94.4.1544 – ident: e_1_2_5_9_1 doi: 10.1016/0165-0270(94)90144-9 – ident: e_1_2_5_7_1 doi: 10.1093/bja/81.2.208 – ident: e_1_2_5_43_1 doi: 10.1124/jpet.108.141226 – ident: e_1_2_5_15_1 doi: 10.1016/j.neuroimage.2016.07.030 – ident: e_1_2_5_37_1 doi: 10.1016/j.neuroscience.2005.06.003 – ident: e_1_2_5_10_1 doi: 10.1016/j.brainres.2006.01.053 – ident: e_1_2_5_18_1 doi: 10.1016/0014-2999(80)90515-4 – ident: e_1_2_5_22_1 doi: 10.2174/157015911795016921 – ident: e_1_2_5_28_1 doi: 10.1523/JNEUROSCI.4899-04.2005 – ident: e_1_2_5_36_1 doi: 10.1523/JNEUROSCI.5541-09.2010 – ident: e_1_2_5_44_1 doi: 10.1523/JNEUROSCI.5857-09.2010 – ident: e_1_2_5_19_1 doi: 10.1016/j.pain.2014.07.011 – ident: e_1_2_5_29_1 doi: 10.1038/383819a0 – ident: e_1_2_5_33_1 doi: 10.1038/s41598-017-11120-4 – ident: e_1_2_5_11_1 doi: 10.1152/jn.01343.2005 – ident: e_1_2_5_32_1 doi: 10.1124/jpet.300.2.588 – ident: e_1_2_5_31_1 doi: 10.1152/jn.00575.2001 – ident: e_1_2_5_13_1 doi: 10.1038/nm.4262 – ident: e_1_2_5_39_1 doi: 10.1124/jpet.104.073429 |
| SSID | ssj0013099 |
| Score | 2.5071108 |
| Snippet | Key points
μ‐Opioid receptors (MORs) are expressed peripherally and centrally, but the loci of MORs responsible for clinically relevant opioid analgesia are... μ‐Opioid receptors (MORs) are expressed peripherally and centrally, but the loci of MORs responsible for clinically relevant opioid analgesia are uncertain.... μ-Opioid receptors (MORs) are expressed peripherally and centrally, but the loci of MORs responsible for clinically relevant opioid analgesia are uncertain.... The pain and analgesic systems are complex, and the actions of systemically administered opioids may be mediated by simultaneous activation of μ‐opioid... |
| SourceID | pubmedcentral proquest pubmed crossref wiley |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1661 |
| SubjectTerms | Analgesia Analgesics Capsaicin receptors Dorsal root ganglia fentanyl Hyperalgesia Immunoblotting Inflammation Labeling Morphine Narcotics Neuroscience opiate opioid analgesic tolerance Opioid receptors Pain Pain perception Potentiation presynaptic inhibition Research Paper Sensory neurons Sodium channels (voltage-gated) Spinal cord synaptic transmission TRPV1 |
| Title | μ‐Opioid receptors in primary sensory neurons are essential for opioid analgesic effect on acute and inflammatory pain and opioid‐induced hyperalgesia |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1113%2FJP277428 https://www.ncbi.nlm.nih.gov/pubmed/30578671 https://www.proquest.com/docview/2191287407 https://www.proquest.com/docview/2159980525 https://pubmed.ncbi.nlm.nih.gov/PMC6418757 |
| Volume | 597 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtUwELVQV2x4lceFUhkJwSoldpz4elkhquouoEKtVIlF5FfUiNa5uo8FXfUT2PMrfAMfwZcwYyeBS0FCrCLFY8dJZiZn7MkZQp7rQjkvvcqYcCITlWOZclObiSnEApZb6RLb59vq8ETMTsvTPqsS_4VJ_BDjghtaRvTXaODa9FVIGJINzI44QBeO__liqhbioff85wZCrtRIFC5L1vPOQtdXQ8fNL9E1eHk9S_JX9Bo_Pwe3yYdh4inr5OPeemX27OVvnI7_d2d3yK0eldL9pEZ3yQ0f7pHt_QAR-cUn-oLGPNG4AL9Nvnz7-v3q87t527WOgr_0cyzYQ9tA54m5gi4hNO7gGLkyw5LqhadIUR7Am5xTQMm0S711wCojoCc0pZXQLlBt1ysPLQ5GbEBdL2IaAJ1ruACeTV1hBm1woJaOnkEkvUjj6Pvk5ODN8evDrC_xkFlAQjwz00JXWhiIMzkW_TDC51azXOmcOcMKw8tGKpuzRjWSazeVRggQMNIjs31ePCBboQv-EaFWNgCvVIMkZqIBYMut1jn3uip8U3ozIS-H113bnv8cy3Cc1ykOKurhuU_Is1Gyf3J_kNkZNKburX5Zg_dnWD8glzDE2Az2ipswOvhujTIlRLhYPXBCHiYFGy8Cvlci3-CEyA3VGwWQC3yzJbRnkRO8EgxLE8BNRs3667zr49kRLkvwx_8s-YTcBJSoUuLdDtlaLdb-KSCxldmNNrcbl8h-ACBBNRo |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1NbtQwFLaqsoANf-VnoICR-FmlTRwnThYsKko1nZZSoanUXXBsR41onagzIzSsOAJ7jsAVOALiEJyE9-IkMBQkNl2wihS_2I7zfu2X7xHySIapNsKkXsA193isAy_VifJ4ArGAYkpoh_a5Fw8P-OgwOlwin7t_YRw-RL_hhpLR6GsUcNyQbqUc0QZG-wx8F5a0GZU7Zv4O4rXJs-1N-LiPGdt6MX4-9NqSAp4Cy8u8PAllLHkOcQ3DIhM5N76SgZ9KP9B5EOYsKkSq_KBIC8GkTkTOORDkwiCSug_jgr6_gAXEEah_8zX7eWThp2kPTS6ioEW6hbmudzNdtH1nHNqzeZm_-suNwdu6Qr52S-XyXN6uzab5mnr_G4rkf7KWV8nl1vGmG05SrpElY6-TlQ0rp9XJnD6hTSpsc8awQj59-_L9w8dXdVmVmoJJMDXWJKKlpbUD56ATiP4ruDZwoHZC5amhiMJuQWEeUwgEaOWelhYLqYAoUJc5QytLpZpNDbRo6LEAiTxpMh1oLWEAvOsehRmUVoPkaXo0r3HrEPuRN8jBuSzTTbJsK2tuE6pEAR5kWiBOGy_Ad2dKSp8ZGYemiEw-IE87_spUC_GOlUaOMxfqhVn3nQfkYU_ZrtwfaFY7Fs1axTbJwMAFWCLBF9BF3wwqCc-ZpDXVDGkiCOKxQOKA3HIc3Q8C5kUgpOKAiAVe7wkQ7nyxxZZHDex5zAOsvgAv2bDyX-edjUf7uPPC7vwz5QNycTh-uZvtbu_t3CWXwClOXZ7hKlmens7MPXA8p_n9RuApeXPeUvEDDGmQZg |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1NbtQwFLaqIiE2_JWfgQJG4meVNvF44vGCRcUwaqeojFArdRcc21EjWifqZISGFUdgzw04AzdA4hCchPfiJDAUJDZdsIoUv9iO837tl-8R8kj1pbHCyiDihgc8NlEgzVAHfAixgGZaGI_2uRdvH_DJ4eBwhXxu_4Xx-BDdhhtKRq2vUcBLkzVCjmADkykD14UNm4TKXbt4B-Ha7NnOCL7tY8bGL_afbwdNRYFAg-FlQTrsq1jxFMIahjUmUm5DraJQqjAyadRP2SATUodRJjPBlBmKlHMgSIVFIPUQxgV1f4HHocQyEaPX7OeJRShlh0wuBlEDdAtz3Wxnumz6zvizZ9Myf3WXa3s3vkK-tivl01zebsyrdEO__w1E8v9YyqvkcuN20y0vJ9fIinXXydqWU1VxsqBPaJ0IW58wrJFP3758__DxVZkXuaFgEGyJFYlo7mjpoTnoDGL_Aq41GKibUXVqKWKwO1CXxxTCAFr4p5XDMiogCNTnzdDCUaXnlYUWAz1mII8ndZ4DLRUMgHf9ozCD3BmQO0OPFiVuHGI_6gY5OJdluklWXeHsbUK1yMB_lBmitPEMPHemlQqZVXHfZgOb9sjTlr0S3QC8Y52R48QHev2k_c498rCjbFbuDzTrLYcmjVqbJWDeIiyQEAroomsGhYSnTMrZYo40AwjhsTxij9zyDN0NAsZFIKBij4glVu8IEOx8ucXlRzXoecwjrL0AL1lz8l_nnexPprjvwu78M-UDcnE6Gicvd_Z275JL4BFLn2S4Tlar07m9B15nld6vxZ2SN-ctFD8AyAaPFQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%CE%BC-Opioid+receptors+in+primary+sensory+neurons+are+essential+for+opioid+analgesic+effect+on+acute+and+inflammatory+pain+and+opioid-induced+hyperalgesia&rft.jtitle=The+Journal+of+physiology&rft.au=Sun%2C+Jie&rft.au=Chen%2C+Shao-Rui&rft.au=Chen%2C+Hong&rft.au=Pan%2C+Hui-Lin&rft.date=2019-03-01&rft.eissn=1469-7793&rft.volume=597&rft.issue=6&rft.spage=1661&rft_id=info:doi/10.1113%2FJP277428&rft_id=info%3Apmid%2F30578671&rft.externalDocID=30578671 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3751&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3751&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3751&client=summon |